Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rahm Sensor Development is a medical technology company specializing in non-contact, AI-driven physiological and safety monitoring. Utilizing patented Doppler Radar and sensor fusion technology, the company’s Guardian™ platform enables continuous tracking of vital signs like respiratory rate and pulse, as well as behavioral anomalies, without the need for wearables or physical contact. Its primary products include Cell-Guardian™, designed for safety monitoring in correctional facilities, and Silver-Guardian™, tailored for elder care and skilled nursing environments. Rahm’s technology aims to improve patient outcomes and staff efficiency while reducing triggers for trauma-impacted individuals. The company has achieved FDA Class I registration and is actively pursuing Class II clearance for its medical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rahm Sensor Development.